UL
Ulys LLC Portfolio holdings
AUM
$25.4M
This Quarter Return
+21.77%
1 Year Return
+201.03%
3 Year Return
-31.51%
5 Year Return
-50.88%
10 Year Return
–
AUM
$34.8M
AUM Growth
+$34.8M
(+22%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-600.02%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Lexicon Pharmaceuticals
LXRX
|
$209M |
| 2 |
CERE
CERES, INC. COMMON STOCK NEW
CERE
|
$56K |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Lexicon Pharmaceuticals
LXRX
$400M
| $34.8M | 99.98% | 4,321,214 -25,927,291 | -86% | -$209M |
|
|
CERE
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $8K | 0.02% | 3,891 -27,240 | -88% | -$56K |
|